Literature DB >> 20052454

Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?

P M Humpert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20052454     DOI： 10.1007/s00125-009-1652-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  29 in total

1.  Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus.

Authors:  Maria Cristina Bravi; Antonietta Armiento; Oriana Laurenti; Maria Cassone-Faldetta; Orietta De Luca; Arianna Moretti; Giancarlo De Mattia
Journal:  Metabolism       Date:  2006-05       Impact factor: 8.694

2.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

3.  SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.

Authors:  Per M Humpert; Renate Neuwirth; Marco J Battista; Olga Voronko; Maximilian von Eynatten; Ilze Konrade; Gottfried Rudofsky; Thoralf Wendt; Andreas Hamann; Michael Morcos; Peter P Nawroth; Angelika Bierhaus
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Insulin therapy improves endothelial function in type 2 diabetes.

Authors:  S Vehkavaara; S Mäkimattila; A Schlenzka; J Vakkilainen; J Westerbacka; H Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

Review 5.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

6.  Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.

Authors:  P Mohanty; W Hamouda; R Garg; A Aljada; H Ghanim; P Dandona
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

7.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

8.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

Authors:  H O Steinberg; G Brechtel; A Johnson; N Fineberg; A D Baron
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

10.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321
View more
  2 in total

1.  Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes.

Authors:  R Boizel; G Bruttmann; P Y Benhamou; S Halimi; F Stanke-Labesque
Journal:  Diabetologia       Date:  2010-06-10       Impact factor: 10.122

2.  Continuous glucose monitoring as a close to real life alternative to meal studies - a pilot study with a functional drink containing amino acids and chromium.

Authors:  Azat Samigullin; Per M Humpert; Elin Östman
Journal:  Front Med Technol       Date:  2022-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.